Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults

IMPORTANCE: Immune checkpoint inhibitors (ICIs) have improved survival in patients with advanced melanoma but can be associated with a spectrum of immune-related adverse events (AEs), including both autoimmune-related AEs and other immune-related inflammatory AEs. These associations have primarily b...

Descripción completa

Detalles Bibliográficos
Autores principales: Schonfeld, Sara J., Tucker, Margaret A., Engels, Eric A., Dores, Graça M., Sampson, Joshua N., Shiels, Meredith S., Chanock, Stephen J., Morton, Lindsay M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941351/
https://www.ncbi.nlm.nih.gov/pubmed/35315916
http://dx.doi.org/10.1001/jamanetworkopen.2022.3461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941351/
https://www.ncbi.nlm.nih.gov/pubmed/35315916
http://dx.doi.org/10.1001/jamanetworkopen.2022.3461

Ejemplares similares